Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christina Mundy
The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55
Journal of NeuroImmune Pharmacology
Neuroscience
Allergy
Immunology
Pharmacology
Related publications
Synergistic Antinociception by the Cannabinoid Receptor Agonist Anandamide and the PPAR-α Receptor Agonist GW7647
European Journal of Pharmacology
Pharmacology
GPR55 Regulates Cannabinoid 2 Receptor-Mediated Responses in Human Neutrophils
Cell Research
Cell Biology
Molecular Biology
Functional Characterization of the Novel Cannabinoid Receptor GPR55 and Its Modulation by CB1 and CB2 Receptors
BMC Pharmacology
The Putative Cannabinoid Receptor GPR55 Defines a Novel Autocrine Loop in Cancer Cell Proliferation
Oncogene
Cancer Research
Genetics
Molecular Biology
Interactions of the G Protein-Coupled Receptor-Associated Sorting Proteins (GASP) 1 and 2 With the Novel Cannabinoid Receptor GPR55
BMC Pharmacology
The Endogenous Cannabinoid, Anandamide, Inhibits Dopamine Transporter Function by a Receptor-Independent Mechanism
Journal of Neurochemistry
Biochemistry
Molecular Neuroscience
Cellular
The Hypocretin/Orexin Receptor-1 as a Novel Target to Modulate Cannabinoid Reward
Biological Psychiatry
Biological Psychiatry
Anandamide, an Endogenous Cannabinoid Receptor Ligand, Also Interacts With 5-Hydroxytryptamine (5-Ht) Receptor.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Physiological and Behavioural Effects of the Endogenous Cannabinoid, Arachidonylethanolamide (Anandamide), in the Rat
British Journal of Pharmacology
Pharmacology